iRadimed IRMD Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 76.7%-0.2pp | 76.9%+0.4pp | 76.5%-0.9pp | 77.4%+0.8pp | |
| Operating margin | 31.2%+1.2pp | 30%-0.6pp | 30.6%+1.2pp | 29.3%+5.8pp | |
| Net margin | 26.8%+0.6pp | 26.3%0.0pp | 26.2%+2.2pp | 24.1%+1.8pp | |
| Returns | |||||
| Return on equity | 24.8%+0.5pp | 24.3%+0.6pp | 23.7%+6.1pp | 17.6%+3.6pp | |
| Efficiency | |||||
| Asset turnover | 0.8×0.0× | 0.8×0.0× | 0.7×+0.1× | 0.6×+0.1× | |
| Liquidity | |||||
| Current ratio | 8×-0.9× | 8.8×+4.2× | 4.7×-4.4× | 9.1×-2.1× | |
| Per Share | |||||
| Book value per share | $7.36+8.4% | $6.79+21.0% | $5.61-3.7% | $5.83+1.7% | |
| Valuation | |||||
| Market capitalization | $1.21B+63.4% | $697.04M+16.4% | $599.06M+68.5% | $355.5M-37.7% | |
| Price / earnings | 51.3×+13.8× | 36.2×+1.4× | 34.8×+7.1× | 27.7×-33.4× | |
| Price / sales | 14×+4.2× | 9.5×+0.4× | 9.1×+2.5× | 6.7×-7.0× | |
| Price / book | 12.3×+4.1× | 8×-0.4× | 8.4×+3.6× | 4.8×-3.1× | |
| Dividend yield | 1.3%+0.2pp | 2%— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are iRadimed's profit margins?
- iRadimed (IRMD) runs a 76.8% gross margin and a 32.4% operating margin, with a 27.4% net margin.
- Where do iRadimed's ratios come from?
- Every ratio is computed from iRadimed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
